Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparins

A standard validation protocol adapted to the chromogenic assay of anti-Xa activity of low-molecular-weight heparins was used in a multicenter study to assess its suitability for comparing and evaluating analytical hemostasis systems. The protocol included: familiarization with the system (repeatabi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical chemistry (Baltimore, Md.) Md.), 1996-08, Vol.42 (8), p.1223-1230
Main Authors: Houbouyan, L, Boutiere, B, Contant, G, Dautzenberg, MD, Fievet, P, Potron, G, Vassault, A, Gourmelin, Y
Format: Article
Language:English
Subjects:
Autoanalysis - statistics & numerical data
Biological and medical sciences
Blood coagulation
Chromogenic Compounds
Factor Xa Inhibitors
Hemostasis
Heparin - pharmacology
Humans
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Molecular Weight
Quality Control
Regression Analysis
Reproducibility of Results
Sensitivity and Specificity
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A standard validation protocol adapted to the chromogenic assay of anti-Xa activity of low-molecular-weight heparins was used in a multicenter study to assess its suitability for comparing and evaluating analytical hemostasis systems. The protocol included: familiarization with the system (repeatability); assessment of limits of linearity, detection limits, and cross-contamination; and validation (reproducibility and accuracy of measurements of treated patients' plasmas). We calibrated the systems with the same range of lyophilized plasmas daily and evaluated repeatability and reproducibility by using a single batch of lyophilized plasmas at three anti-Xa activities. The two automated systems tested [SB 300 (Gilford) and ACL (IL)] and the two semiautomated systems [ST 888 (D. Stago) and Chromotimer (Behring)] gave similar mean values. Dispersion of results was lower with the automated systems than with the semiautomated ones, especially at low anti-Xa activities, a tendency that also was observed for reproducibility. Because each analytical system gave linear results for activities as great as 1000 IU/L, suitable sample dilution is advisable for higher anti-Xa activities. Accuracy was greater in the automated systems. We conclude that this protocol is feasible and is applicable to validation of other analytical hemostasis instruments, in particular the latest generation of fully automated instruments.
ISSN:0009-9147
1530-8561
DOI:10.1093/clinchem/42.8.1223